wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38753307-0BD92912-C9A3-4F8F-8F0A-6D31D2653A85
Q38753307-0BD92912-C9A3-4F8F-8F0A-6D31D2653A85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38753307-0BD92912-C9A3-4F8F-8F0A-6D31D2653A85
Signaling Pathways and Emerging Therapies in Multiple Myeloma.
P2860
Q38753307-0BD92912-C9A3-4F8F-8F0A-6D31D2653A85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38753307-0BD92912-C9A3-4F8F-8F0A-6D31D2653A85
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
294b6d3b58499109edde1394f6cdd639ea44b0ac
P2860
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs.